Didanosine
Back to searchMolecule Structure
Scientific Name
Didanosine
Description of the Drug
Didanosine is a reverse transcriptase inhibitor used to treat HIV.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00900
http://www.drugbank.ca/drugs/DB00900
Brand Name(s)
Didanosine, Videx, Videx ec
Company Owner(s)
Bristol Myers Squibb Co, Aurobindo Pharma Ltd, Mylan Pharmaceuticals Inc, Barr Laboratories Inc, Bristol Myers Squibb Co Pharmaceutical Research Institute, Bristol-Myers Squibb Co
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Human immunodeficiency virus type 1 reverse transcriptase | SINGLE PROTEIN | INHIBITOR | CHEMBL247 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3363 | ||||
PharmGKB | PA449301 | ||||
Human Metabolome Database | HMDB0015037 | ||||
DrugBank | DB00900 | ||||
PubChem: Thomson Pharma | 15121788 | 15121787 | 14847321 | 15196316 | |
PubChem | 135398739 | ||||
Mcule | MCULE-2844514954 | ||||
LINCS | LSM-6017 | ||||
Nikkaji | J261.930J | ||||
PDBe | 2DI | ||||
BindingDB | 50404252 | ||||
EPA CompTox Dashboard | DTXSID6022927 | ||||
DrugCentral | 869 | ||||
Brenda | 148764 | 1813 | 51621 | 124179 | 14441 |
ChemicalBook | CB0680765 | ||||
Guide to Pharmacology | 4833 | ||||
rxnorm | VIDEX | VIDEX EC | DIDANOSINE | ||
PubChem: Drugs of the Future | 12014245 | ||||
KEGG Ligand | C06953 | ||||
ChEBI | 490877 | ||||
ZINC | ZINC000013597823 |